tiprankstipranks
Bioventix PLC (GB:BVXP)
LSE:BVXP

Bioventix (BVXP) Share Price & Analysis

4 Followers

BVXP Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range3,306.71p - 5,024.61p
Previous Close4,600p
Volume1.19K
Average Volume (3M)6.37K
Market Cap
£240.10M
Enterprise Value234.39M
Total Cash (Recent Filing)£5.72M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)27.7
Beta0.22
Oct 28, 2024
EPS EstimateN/A
Dividend Yield3.3%
Share Statistics
EPS (TTM)1.66
Shares Outstanding5,209,333
10 Day Avg. Volume2,360
30 Day Avg. Volume6,374
Standard Deviation0.09
R-Squared0.00794
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)1829.25
Price to Sales (P/S)3888.13
Price to Cash Flow (P/CF)2275.10
P/FCF Ratio2275.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

5.96%0.61%0.00%93.43%
0.00% Other Institutional Investors
93.43% Public Companies and
Individual Investors

BVXP FAQ

What was Bioventix PLC’s price range in the past 12 months?
Bioventix PLC lowest share price was 3306.71p and its highest was 5024.61p in the past 12 months.
    What is Bioventix PLC’s market cap?
    Currently, no data Available
    When is Bioventix PLC’s upcoming earnings report date?
    Bioventix PLC’s upcoming earnings report date is Oct 28, 2024 which is in 187 days.
      How were Bioventix PLC’s earnings last quarter?
      Bioventix PLC released its earnings results on Mar 25, 2024. The company reported 0.76p earnings per share for the quarter, beating the consensus estimate of N/A by 0.76p.
        Is Bioventix PLC overvalued?
        According to Wall Street analysts Bioventix PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Bioventix PLC pay dividends?
          Bioventix PLC pays a Annually dividend of 68p which represents an annual dividend yield of 3.3%. See more information on Bioventix PLC dividends here
            What is Bioventix PLC’s EPS estimate?
            Bioventix PLC’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Bioventix PLC have?
            Bioventix PLC has 5,219,656 shares outstanding.
              What happened to Bioventix PLC’s price movement after its last earnings report?
              Bioventix PLC reported an EPS of 0.76p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.717%.
                Which hedge fund is a major shareholder of Bioventix PLC?
                Currently, no hedge funds are holding shares in GB:BVXP
                ---

                Bioventix Stock Smart Score

                6
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Company Description

                Bioventix PLC

                Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drugs of abuse testing. The company's portfolio of products includes drugs which are applicable in the areas of cardiology, fertility, infectious diseases, oncology, and vitamin D disorder.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Genedrive
                HemoGenyx Pharmaceuticals Plc
                EKF Diagnostics Holdings
                Synairgen
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis